Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis
Clinical trial NCT03006146 · COMPLETED
Trial details
- NCT number
- NCT03006146
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-13
- Primary completion
- 2021-06-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.